Atlas Trials

Lung Function and Patient Preference With QVA149 vs. Tiotropium in COPD Patients

Clinical trial NCT02125734 · COMPLETED

Trial details

NCT number
NCT02125734
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Obstructive Pulmonary DiseaseCOPD
Start date
2014-04-01
Primary completion
2015-01-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.